Lepu Medical Plans to Apply for 315 Million Yuan M&A Loan

CLS··CN·Read original
2▲2 ▼0Impact / 5
Summary · why it matters

Lepu Medical announced that its board of directors has approved a proposal to apply for an M&A loan of no more than 315 million yuan from Industrial Bank. The loan will be used to pay or replace the transfer payment for all intangible assets involved in Lepu Pharmaceutical's acquisition of Betanin from Bio-Thera Solutions as the marketing authorization holder, including the drug marketing license, intellectual property, production technology, and commercialization rights.

Impact on assets 2

Others▲ · 2 stocks
Bio-Thera Solutions Ltd
688177
▲ PositiveCapitalrelevance

Bio-Thera Solutions is selling intangible assets, receiving payment that strengthens its balance sheet.

© 2026 MarketIVNews